Allurion (ALUR) Revenue & Revenue Breakdown
Allurion Revenue Highlights
Latest Revenue (Y)
$32.11M
Latest Revenue (Q)
$2.66M
Main Geography (Y)
All Other Countries
Allurion Revenue by Period
Allurion Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | $32.11M | -39.94% |
| 2023-12-31 | $53.47M | -16.73% |
| 2022-12-31 | $64.21M | 67.91% |
| 2021-12-31 | $38.24M | 100.00% |
| 2020-12-31 | - | - |
Allurion generated $32.11M in revenue during NA 2024, up -39.94% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
Allurion Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | $2.66M | -21.34% |
| 2025-06-30 | $3.38M | -39.44% |
| 2025-03-31 | $5.58M | -0.20% |
| 2024-12-31 | $5.59M | 4.17% |
| 2024-09-30 | $5.37M | -54.39% |
| 2024-06-30 | $11.77M | 25.36% |
| 2024-03-31 | $9.39M | 13.98% |
| 2023-12-31 | $8.23M | -54.75% |
| 2023-09-30 | $18.20M | 40.43% |
| 2023-06-30 | $12.96M | -7.90% |
| 2023-03-31 | $14.07M | -26.65% |
| 2022-12-31 | $19.18M | 19.42% |
| 2022-09-30 | $16.06M | -1.14% |
| 2022-06-30 | $16.25M | 27.82% |
| 2022-03-31 | $12.71M | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2021-09-30 | - | 100.00% |
| 2021-06-30 | - | 100.00% |
| 2021-03-31 | - | 100.00% |
| 2020-12-31 | - | - |
Allurion generated $2.66M in revenue during Q3 2025, up -21.34% compared to the previous quarter, and up 22.59% compared to the same period a year ago.
Allurion Revenue Breakdown
Allurion Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 24 |
|---|---|
| SPAIN | $4.01M |
| All Other Countries | $24.04M |
| FRANCE | $2.49M |
Latest
Allurion's latest annual revenue breakdown by geography, as of Dec 24: All Other Countries (78.72%), SPAIN (13.13%), and FRANCE (8.15%).
Quarterly Revenue by Country
| Country | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 |
|---|---|---|---|---|---|---|---|
| SPAIN | $282.00K | $786.00K | $749.00K | - | $3.00M | $1.45M | $1.11M |
| ITALY | $418.00K | $436.00K | $511.00K | - | - | - | - |
| All Other Countries | $941.00K | $1.88M | $4.15M | $6.89M | $3.35M | $8.45M | $5.35M |
| AUSTRALIA | $24.00K | $543.00K | - | - | - | - | - |
| ARGENTINA | $272.00K | - | - | - | - | - | - |
| EGYPT | $450.00K | $600.00K | - | - | - | - | - |
| CHILE | $271.00K | - | - | - | - | - | - |
| FRANCE | - | $274.00K | - | $2.43M | $1.87M | $1.67M | - |
Latest
Allurion's latest quarterly revenue breakdown by geography, as of Sep 25: All Other Countries (35.40%), EGYPT (16.93%), ITALY (15.73%), SPAIN (10.61%), ARGENTINA (10.23%), CHILE (10.20%), and AUSTRALIA (0.90%).
Allurion Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADAP | Adaptimmune Therapeutics | $178.03M | $7.29M |
| ALUR | Allurion | $32.11M | $2.66M |
| LFWD | Lifeward | $25.66M | $6.20M |
| VVOS | Vivos Therapeutics | $15.03M | $6.78M |
| CODX | Co-Diagnostics | $3.92M | $162.91K |
| XAIR | Beyond Air | $1.16M | $1.82M |
| ERNA | Ernexa Therapeutics | $582.00K | - |
| COCH | Envoy Medical | $316.00K | $42.00K |
| PRPH | ProPhase Labs | - | $883.00K |
| NVNO | enVVeno Medical | - | - |
| AEMD | Aethlon Medical | - | - |